Vir Biotechnology (VIR) Gross Margin (2020 - 2025)
Vir Biotechnology (VIR) reported Gross Margin of 99.09% for Q2 2025, up 78.0% on a YoY basis from 55.67% in Q2 2024, and down 0.91% sequentially from 100.0% in Q1 2025.
Vir Biotechnology (VIR) Gross Margin (2020 - 2025) Analysis & Trends
Vir Biotechnology (VIR) has 6 years of Gross Margin data on file, last reported at 99.09% in Q2 2025.
- For the quarter ending Q2 2025, Gross Margin rose 78.0% year-over-year to 99.09%; the trailing twelve-month figure through Jun 2025 stood at 96.08% (down 264.0% YoY), and the FY2025 full-year result was 99.96%, up 110.0% from the prior year.
- Gross Margin eased to 99.09% in Q2 2025, from 100.0% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 100.0% in Q1 2021 to a low of 31.28% in Q2 2022.
- A 5-year average of 92.81% and a median of 97.44% in 2024 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin sank 6804 bps in 2022 and jumped 6814 bps in 2023, its largest moves.
- Tracing VIR's Gross Margin over 5 years: stood at 93.0% in 2021, then decreased by 6 bps to 87.86% in 2022, then rose by 8 bps to 95.25% in 2023, then fell by 1 bps to 94.47% in 2024, then rose by 5 bps to 99.09% in 2025.
- Business Quant data shows VIR's Gross Margin at 99.09% in Q2 2025, 100.0% in Q1 2025, and 94.47% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 88.95% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 90.68% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Vir Biotechnology | 1.28 Bn | 1.28 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 99.09% |
| Mar 31, 2025 | 100.00% |
| Dec 31, 2024 | 94.47% |
| Sep 30, 2024 | 97.90% |
| Jun 30, 2024 | 98.31% |
| Mar 31, 2024 | 99.89% |
| Dec 31, 2023 | 95.25% |
| Sep 30, 2023 | 98.56% |
| Jun 30, 2023 | 99.42% |
| Mar 31, 2023 | 96.97% |
| Dec 31, 2022 | 87.86% |
| Sep 30, 2022 | 94.06% |
| Jun 30, 2022 | 31.28% |
| Mar 31, 2022 | 92.69% |
| Dec 31, 2021 | 93.00% |
| Sep 30, 2021 | 92.44% |
| Jun 30, 2021 | 99.32% |
| Mar 31, 2021 | 100.00% |
| Dec 31, 2020 | 100.00% |
| Sep 30, 2020 | 100.00% |